Gluten Intolerance Treatment Market Size

  • Report ID: 5081
  • Published Date: Jun 28, 2023
  • Report Format: PDF, PPT

Gluten Intolerance Treatment Market Size

Gluten Intolerance Treatment Market size is anticipated to surpass USD 3 Billion by the end of 2035, growing at a CAGR of 14% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry of gluten intolerance treatment was around USD 650 Million. The market growth is backed by the growing research on how to reverse gluten intolerance. This is resulting in the rise in clinical trials and the development of workable gluten intolerance treatments.

The rising incidence of gluten-related disorders (GRDs) and the rise in their global prevalence is predicted in about 5% of the population. The ingestion of the gluten proteins present in wheat, barley, and rye is considered the main cause of GRDs. GRDs refer to a group of conditions that are heterogeneous, reflecting their autoimmune, allergic, and non-autoimmune-allergic etiology. The increasing adoption of gluten intolerance treatment by people suffering from GRDs is will positively impact the growth of the market.


Gluten Intolerance Treatment Market

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5081
  • Published Date: Jun 28, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of autoimmune, allergic, and non-autoimmune-allergic GRDs and the rising damage of gut flora are the major factors driving the growth of the gluten intolerance treatment market.

The market of gluten intolerance treatment is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Precigen, Inc., ImmunogenX, Inc., Calypso Biotech BV, Zedira GmbH, and FunZyme BioTechnologies S.A.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type. gluten-related disorders, distribution channel, and region.

The celiac disease segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Challenges in diagnoses are estimated to be the growth hindering factors for the market expansion.

The market in the Europe region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying